We are live on ! Find out more
Mackenzie Financial

Mackenzie Financial Portfolio holdings

AUM $83.3B
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
-3.91%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$59.5B
AUM Growth
-$6.44B
Cap. Flow
-$1.84B
Cap. Flow %
-3.1%
Top 10 Hldgs %
21.6%
Holding
1,631
New
128
Increased
589
Reduced
587
Closed
165

Top Buys

Rank Stock Value
1
TRI icon
Thomson Reuters
TRI
+$119M
2
ENB icon
Enbridge
ENB
+$97.8M
3
ORCL icon
Oracle
ORCL
+$95.5M
4
AAPL icon
Apple
AAPL
+$86M
5
GIB icon
CGI
GIB
+$82.4M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$313M
2
COST icon
Costco
COST
+$123M
3
BN icon
Brookfield
BN
+$114M
4
ON icon
ON Semiconductor
ON
+$110M
5
CP icon
Canadian Pacific Kansas City
CP
+$110M

Sector Composition

Rank Sector Weight
1 Financials 20.1%
2 Technology 19.75%
3 Industrials 12.94%
4 Healthcare 9.73%
5 Energy 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNDT icon
1426
Conduent
CNDT
$244M
$38.9K ﹤0.01%
11,154
VISN
1427
Vistance Networks Inc
VISN
$2.65B
$38.5K ﹤0.01%
12,565
-115,620
-90% -$473K
OPK icon
1428
Opko Health
OPK
$985M
$38.5K ﹤0.01%
25,843
CDE icon
1429
Coeur Mining
CDE
$15.4B
$38.3K ﹤0.01%
18,217
KYNB
1430
Kyntra Bio
KYNB
$27.2M
$38.1K ﹤0.01%
2,060
+1,091
+113% +$42.8K
DHX icon
1431
DHI Group
DHX
$182M
$36.1K ﹤0.01%
+12,418
New +$44.3K
AVAH icon
1432
Aveanna Healthcare
AVAH
$2.04B
$35.8K ﹤0.01%
+31,143
New +$48.2K
PSTX
1433
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$35.8K ﹤0.01%
15,914
-2,918
-15% -$6.12K
UIS icon
1434
Unisys
UIS
$209M
$35.5K ﹤0.01%
10,308
TELL
1435
DELISTED
Tellurian Inc.
TELL
$35.1K ﹤0.01%
33,439
RIGL icon
1436
Rigel Pharmaceuticals
RIGL
$681M
$33.8K ﹤0.01%
3,312
+402
+14% +$4.84K
CDXS icon
1437
Codexis
CDXS
$151M
$32.2K ﹤0.01%
16,171
ESPR
1438
DELISTED
Esperion Therapeutics
ESPR
$31.5K ﹤0.01%
32,618
+5,341
+20% +$7.73K
CCO icon
1439
Clear Channel Outdoor Holdings
CCO
$1.23B
$31.3K ﹤0.01%
22,230
MTTR
1440
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$29.9K ﹤0.01%
14,255
FCEL icon
1441
FuelCell Energy
FCEL
$1.73B
$28.9K ﹤0.01%
808
FUBO icon
1442
FuboTV Inc
FUBO
$261M
$28.3K ﹤0.01%
963
DHC
1443
Diversified Healthcare Trust
DHC
$2.15B
$28.1K ﹤0.01%
15,549
RNAC icon
1444
Cartesian Therapeutics
RNAC
$229M
$26.2K ﹤0.01%
923
PL icon
1445
Planet Labs
PL
$7.3B
$25.6K ﹤0.01%
10,119
SPCE icon
1446
Virgin Galactic
SPCE
$328M
$24.8K ﹤0.01%
747
SGMO
1447
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$24.5K ﹤0.01%
42,796
+12,228
+40% +$13.1K
DM
1448
DELISTED
Desktop Metal, Inc.
DM
$24.3K ﹤0.01%
1,814
SLGC
1449
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$23.5K ﹤0.01%
10,200
CDTX
1450
DELISTED
Cidara Therapeutics
CDTX
$23.4K ﹤0.01%
1,263
+135
+12% +$2.65K

Similar funds

Mackenzie Financial's Q3 2023 Portfolio in Review

As of Q3 2023, Mackenzie Financial held 1,631 positions worth $59.5B, down 9.8% from $65.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Mackenzie Financial withdrew a net $1.84B in Q3 2023, closing 165 positions and reducing 587 holdings. Its most notable exit was Black Knight, Inc. Common Stock, an estimated $84.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.

Against the trend, Mackenzie Financial opened a new position in Axonics, Inc. Common Stock worth $68.5M.

  • Mackenzie Financial's largest Q3 2023 buy was Axonics, Inc. Common Stock: 1,239,133 shares worth $68.5M.
  • Mackenzie Financial added most to Thomson Reuters in Q3 2023, an estimated $119M increase.
  • Mackenzie Financial's biggest Q3 2023 reduction was Danaher, cutting an estimated $313M.
  • Mackenzie Financial fully exited Black Knight, Inc. Common Stock in Q3 2023, selling an estimated $84.9M.
  • Mackenzie Financial's ten largest holdings make up 22% of its $59.5B portfolio in Q3 2023.
  • Mackenzie Financial opened 128 new positions and closed 165 in Q3 2023.
  • Mackenzie Financial's portfolio value fell 9.8% quarter-over-quarter to $59.5B.

Based on Mackenzie Financial's 13F filing for Q3 2023, filed 25 Oct 2023.